Targeted Therapy for Early-Stage Lung Cancer?
A trial of the molecularly targeted therapy osimertinib for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence.
Home > Patients, Caregivers, and Advocates > Research > Targeted Therapy for Early-Stage Lung Cancer?
A trial of the molecularly targeted therapy osimertinib for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence.